Stakeholders’ Views on Early Diagnosis for Alzheimer’s Disease, Clinical Trial Participation and Amyloid PET Disclosure: A Focus Group Study
Crossref DOI link: https://doi.org/10.1007/s11673-019-09901-9
Published Online: 2019-03-13
Published Print: 2019-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vanderschaeghe, Gwendolien http://orcid.org/0000-0002-7258-2025
Vandenberghe, Rik
Dierickx, Kris
Funding for this research was provided by:
IWT (The project number is 120,836, and the title is, ?Biomarker-Based Adaptive Development in AD.?)
Text and Data Mining valid from 2019-03-01
Article History
Received: 13 January 2018
Accepted: 18 January 2019
First Online: 13 March 2019